DENTSPLY SIRONA (NASDAQ:XRAY) Stock Rating Lowered by StockNews.com

DENTSPLY SIRONA (NASDAQ:XRAY) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday.

A number of other equities research analysts also recently commented on the stock. Needham & Company LLC dropped their price objective on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating on the stock in a research report on Friday. Leerink Partnrs reiterated an “outperform” rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Evercore ISI decreased their target price on shares of DENTSPLY SIRONA from $40.00 to $35.00 and set an “outperform” rating on the stock in a research report on Friday. Piper Sandler reaffirmed a “neutral” rating and issued a $32.00 target price (down from $35.00) on shares of DENTSPLY SIRONA in a report on Friday. Finally, SVB Leerink initiated coverage on DENTSPLY SIRONA in a research report on Monday, February 26th. They set an “outperform” rating and a $42.00 target price on the stock. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, DENTSPLY SIRONA presently has an average rating of “Moderate Buy” and a consensus price target of $36.90.

DENTSPLY SIRONA Stock Performance

XRAY traded down $0.09 during trading on Friday, reaching $28.29. 4,506,596 shares of the company’s stock were exchanged, compared to its average volume of 3,342,785. The stock has a market capitalization of $5.87 billion, a P/E ratio of -45.63, a price-to-earnings-growth ratio of 1.22 and a beta of 1.00. DENTSPLY SIRONA has a 1 year low of $26.27 and a 1 year high of $41.65. The company’s fifty day simple moving average is $32.13 and its 200-day simple moving average is $32.71. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, meeting analysts’ consensus estimates of $0.42. The business had revenue of $953.00 million during the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The company’s quarterly revenue was down 2.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.39 earnings per share. As a group, research analysts predict that DENTSPLY SIRONA will post 2.05 earnings per share for the current fiscal year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several institutional investors and hedge funds have recently modified their holdings of XRAY. Bar Harbor Wealth Management bought a new position in shares of DENTSPLY SIRONA in the fourth quarter worth about $4,931,000. DAVENPORT & Co LLC bought a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at approximately $1,220,000. Andra AP fonden increased its holdings in DENTSPLY SIRONA by 20.3% in the 3rd quarter. Andra AP fonden now owns 302,700 shares of the medical instruments supplier’s stock valued at $10,340,000 after buying an additional 51,100 shares during the period. Envestnet Asset Management Inc. lifted its holdings in shares of DENTSPLY SIRONA by 98.1% during the third quarter. Envestnet Asset Management Inc. now owns 347,220 shares of the medical instruments supplier’s stock valued at $11,861,000 after acquiring an additional 171,958 shares during the period. Finally, Mirabella Financial Services LLP acquired a new stake in shares of DENTSPLY SIRONA during the 3rd quarter worth about $802,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.